By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


Start Up


Dyax  Antibody phage display

Company News
Merrimack (MACK) Announces Date Of One-for-Ten Reverse Stock Split 8/31/2017 7:51:42 AM
Merrimack (MACK) Augments Executive Team With Appointment Of Jean Franchi As Chief Financial Officer 8/14/2017 6:32:43 AM
Merrimack (MACK) Reports Second Quarter 2017 Financial Results 8/9/2017 12:39:06 PM
Merrimack (MACK) Announces Timing Of Second Quarter 2017 Investor Conference Call 8/2/2017 12:39:08 PM
Merrimack (MACK) Appoints Thomas Needham As Chief Business Officer 7/24/2017 7:57:31 AM
Merrimack (MACK) Announces Completion Of Enrollment In Phase II CARRIE Study Of MM-141; Data Expected In First Half Of 2018 6/19/2017 6:24:26 AM
Merrimack (MACK) Announces Expansion Of Senior Management Team With Appointment Of Sergio Santillana As Chief Medical Officer And Ellen Forest As Head Of Human Resources 6/8/2017 7:02:15 AM
Merrimack (MACK) CFO To Step Down, Effective June 9 5/26/2017 6:11:17 AM
Merrimack (MACK) Reports First Quarter 2017 Financial Results 5/10/2017 11:29:37 AM
Merrimack (MACK) Announces Timing Of First Quarter 2017 Investor Conference Call 5/3/2017 10:16:33 AM